News
TDSR measures to spur feistier pricing competition among residential developers
Due to smaller pool of buyers.
3 biggest factors that will hurt October developer sales
Barclays explains the likely lull next month.
September developer sales rebound but too little too late
FY13 volumes likely to end -30% yoy.
Half of Singaporeans claim to exercise regularly
Second-highest among surveyed Asia Pacific nations.
See the expected average selling prices for Keppel Land's Tiong Bahru site
Based on OCBC estimates.
SPH to revamp property classification codes in CATS Classified, newspapers
User search experience should improve.
Keppel REIT's third-quarter surge indicates office segment rebound: Moody's
Occupancy rates are going up.
A-REIT reveals outlook for the rest of financial year
Positive on earnings but unsure on occupancy.
Ascendas REIT net property income up 4.1% to 107.1m
Amount available for distribution spiked 9.3%.
Keppel T&T third-quarter net profit rose 4% to $14.1m
Revenue much higher but operating margins tanked.
Here's why Keppel Land's risk profile is rising
Bulk of asset value in development properties.
Keppel Land residential sales boooming in China but slumping in Singapore
China sales quadrupled in one quarter.
Ascendas REIT seen to post strong rent reversions well into FY14
But at a "more modest" clip.
SGX's total revenue seen to fall 10% to $182m
As analyst predicts a softer 1QFY14.
2 main culprits behind M1's weaker data revenue growth
Flat service revenue recorded in 3Q.
Why industrial REITs must now bid goodbye to M&A's heydays
No more easy acquisitions, says analyst.
Read Here
Advertise
Sign Up
Commentary
Green shipping's future: Strategic partnership between public and private finance
The great Singapore family business transition: Why legacy companies are choosing sales over succession
Why SG60 must mark a cybersecurity turning point
What the global financial crisis can teach Singapore about decision-making today
Singapore is ready for EVs, but the industry needs to catch up
Navigating public–private collaboration in Singapore’s health tech and life sciences landscape